What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders

Summary

Biogen raised its earnings guidance and reported progress in its late-stage pipeline. The article discusses implications for shareholders regarding the company's financial outlook and clinical development progress.